-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Beta Bionics, Raises Price Target to $16

Benzinga·09/15/2026 12:41:34
Listen to the news
Baird analyst Jeff Johnson maintains Beta Bionics (NASDAQ:BBNX) with a Neutral and raises the price target from $14 to $16.